Triphenylphosphine → (E)-N-(5-bromo-pyridin-2-yl)-3-cyclohexyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-acrylamide
Reaction equation
C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.BrN1C(=O)CCC1=O.[CH:28]1(/[CH:34]=[C:35](\[C:39]2[CH:44]=[CH:43][C:42]([S:45]([CH3:48])(=[O:47])=[O:46])=[C:41]([C:49]([F:52])([F:51])[F:50])[CH:40]=2)/[C:36]([OH:38])=O)[CH2:33][CH2:32][CH2:31][CH2:30][CH2:29]1.[NH2:53][C:54]1[CH:59]=[CH:58][C:57]([Br:60])=[CH:56][N:55]=1>C(Cl)Cl>[Br:60][C:57]1[CH:58]=[CH:59][C:54]([NH:53][C:36](=[O:38])/[C:35](/[C:39]2[CH:44]=[CH:43][C:42]([S:45]([CH3:48])(=[O:47])=[O:46])=[C:41]([C:49]([F:51])([F:50])[F:52])[CH:40]=2)=[CH:34]/[CH:28]2[CH2:33][CH2:32][CH2:31][CH2:30][CH2:29]2)=[N:55][CH:56]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
A solution of triphenylphosphine (525 mg, 2 mmol) in methylene chloride (12 mL) was cooled to 0° C. and then treated with N-bromosuccinimide (356 mg, 2 mmol). The reaction mixture was stirred at 0° C. for 30 min and then treated with (E)-3-cyclohexyl-2-(4-(methanesulfonyl)-3-(trifluoromethyl)-phenyl)-acrylic acid (prepared in Example 12, 376 mg, 1 mmol). The reaction mixture was stirred at 25° C. for 15 min and then allowed to warm to 25° C. where it was stirred for 1.5 h. The reaction mixture was then treated with 2-amino-5-bromopyridine (519 mg, 3 mmol), and the resulting suspension was stirred for 3 d at 25° C. The reaction mixture was concentrated in vacuo to remove methylene chloride, and the residue was diluted with ethyl acetate (50 mL) and a 1N aqueous hydrochloric acid solution (50 mL). The two layers were separated, and the aqueous layer was extracted with ethyl acetate (1×30 mL). The combined organic extracts were successively washed with a saturated aqueous sodium bicarbonate solution (1×50 mL) and a saturated aqueous sodium chloride solution (1×50 mL). The organic layer was then dried over anhydrous magnesium sulfate, filtered, and concentrated in vacuo. Biotage chromatography (FLASH 40S, Silica, 4/1 to 2/1 hexanes/ethyl acetate) afforded the (E)-N-(5-bromo-pyridin-2-yl)-3-cyclohexyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-acrylamide (44 mg, 8.3%) as an amorphous solid: EI-HRMS m/e calcd for C22H22BrF3N2O3S (M+) 530.0487, found 530.0484.
Workup
- stirringThe reaction mixture was stirred at 25° C. for 15 min
- temperatureto warm to 25° C. where it
- stirringwas stirred for 1.5 h
- stirringthe resulting suspension was stirred for 3 d at 25° C
- concentrationThe reaction mixture was concentrated in vacuo
- customto remove methylene chloride
- additionthe residue was diluted with ethyl acetate (50 mL)
- customThe two layers were separated
- extractionthe aqueous layer was extracted with ethyl acetate (1×30 mL)
- washThe combined organic extracts were successively washed with a saturated aqueous sodium bicarbonate solution (1×50 mL)
- dry with materialThe organic layer was then dried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-8add7bbe1e5440dbbd2c20cd7d0afad5
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06353111B1
Reaction notes
Loading…